Sarcopenia in type 2 diabetes mellitus (review and own observations)
Journal Title: Міжнародний ендокринологічний журнал - Year 2017, Vol 13, Issue 2
Abstract
Background. A review of the literature on sarcopenia syndrome presents its definition, classifications and etiological factors. The main attention is paid to the correlation between sarcopenia and carbohydrate metabolism, in particular, between glycogen content and insulin sensitivity. The publications dealing with the mechanisms of influence of physical activity (short-term and long-term) on carbohydrate metabolism are analyzed. It is emphasized that today there is an evidence base on the role of skeletal muscles in maintaining glucose homeostasis, which justifies the importance of physical activity for the prevention of type 2 diabetes mellitus (DM) and monitoring such patients. Our observations were carried out to compare the frequency of the increase in the percentage of fat tissue (FT) and the reduction in muscle tissue in patients with different body mass index (BMI) and the effects of type 2 DM on these indicators. Materials and methods. A bioimpedance study was performed in 114 patients with type 2 DM aged 52.3 ± 1.7 years and 110 persons of the same age without type 2 DM (control group). Results. In all those surveyed with overweight and obesity, the age norms of percentage of FT were increased, regardless of the presence or absence of type 2 DM. At normal body weight in the control group in almost half of the examinees (52.0 %), there was an increase in the specific weight of the FT, and in the presence of type 2 DM, this index was significantly higher (94.1 %). This suggests that exceeding the age norms for the percentage of FT in persons with normal body weight can be regarded as a risk factor for type 2 DM. Conclusions. The incidence of a decrease in the specific weight of FT in the control group was 8.0 % in normal body weight, 20.0 % — in overweight and 80.0 % — in obesity that indicates the significance of the problem of sarcopenia, primarily in persons with obesity. Against the background of type 2 DM, these rates were significantly higher with normal body weight (41.2 %, p < 0.02), 2 times higher — with overweight, but lower (unreliably) — with obesity (61.1 %). The problem of sarcopenia in DM type 2 is relevant for patients with various BMI.
Authors and Affiliations
O. A. Goncharova
Keywords
Related Articles
- EP ID EP176323
- DOI 10.22141/2224-0721.13.2.2017.100611
- Views 80
- Downloads 0
Genetic Determinism of the Functional Condition of the Endothelium in Patients with Chronic Diffuse Liver Diseases and Disorders of Thyroid Homeostasis
Patients with chronic diffuse of liver disease have a violation of thyroid homeostasis in the form of reduction of free triiodothyronine in the blood serum, as well as thyroid stimulating hormone increasing content and o...
Substantiation for Approaches to Treatment of Latent Autoimmune Diabetes in Adults
The objective of this study was to substantiate the approaches to the treatment of latent autoimmune diabetes in adults on the basis of a comprehensive clinical examination of patients with this form of the disease. Rese...
Peculiarities of biochemical blood parameters and cytokine profile in patients with non-alcoholic fatty liver disease depending on the form of hypothyroidism
Background. The purpose of the study was to investigate the biochemical blood peculiarities and cytokine profile in non-alcoholic fatty liver disease (NAFLD) patients depending on the form of hypothyroidism. Material and...
Comparative evaluation of the influence of diabetic retinopathy progression factors on indices of lipid metabolism in metabolic syndrome
Background. The search and study of new risk factors for the development and progression of diabetic retinopathy (DRP) and their modifying influence on the components of metabolic syndrome in type 2 diabetes mellitus (T2...
Brands and Generics: Criteria for Evaluating the Effectiveness
The article deals with problem of choice in the administration of brands and generics, a review of the literature on the bioequivalence of these drugs is provided.